Myofunctional Therapy for Obstructive Sleep Apnea
ConditionObstructive Sleep Apnea
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Minnesota
About this trial
The purpose of this study is to explore a new way to examine the function of the muscles using a technique called high-resolution manometry. The study will enroll 30 adults with OSA, all of whom will use the myofunctional therapy (MFT) devices for 3 months. High-resolution manometry will be used to measure the amount of pressure generated by the muscles of the throat when drinking water or breathing air, both with and without the MFT devices, and before and after the MFT intervention. If successful, this method can help us understand why sleep improves after MFT.
Eligibility criteria
Qualifiers
Adults aged 18-65
New diagnosis of OSA (AHI ≥ 5) or failure of first-line OSA treatment
Willingness to forego first-line OSA treatment or stop current OSA treatment for 3 months
Disqualifiers
Medical comorbidities that require restricting fluid intake (e.g., dysphagia, renal disease, liver disease, hyponatremia)
Severe nasal obstruction
Severe ankyloglossia
Craniofacial abnormality
Trial design
Treatments tested in this trial
- Myofunctional Therapy
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov